During the past decade, Jeffrey Goodman, MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jeffrey Goodman, MD" are "Atrial Fibrillation" (1 trials), "Bradycardia" (1 trials), "Heart Disease" (1 trials), "Optim Lead Insulation Related Adverse Events" (1 trials) and "Tachycardia" (1 trials). Many other conditions were trialed in "Jeffrey Goodman, MD" in a lesser frequency.

Most popular intervention types in "Jeffrey Goodman, MD" are "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cardiac Rhythm Management device" (1 trials) and "Drug (Direct thrombin or Factor Xa inhibitor)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jeffrey Goodman, MD" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Jeffrey Goodman, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Jeffrey Goodman, MD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jeffrey Goodman, MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".